Genetic alterations (amplification and rearrangement) of D-type cyclins loci in head and neck squamous cell carcinoma of Indian patients: Prognostic significance and clinical implications

Diagnostic Molecular Pathology

Volumn 15, Issue 1, 2006, Pages 7-16

  Sabbir, Md Golam ^a   Dasgupta, Santanu ^b   Roy, Anup ^c   Bhoumik, Anup ^a   Dam, Aniruddha ^a   Roychoudhury, Susanta ^d   Panda, Chinmay Kumar ^a  

^a CHITTARANJAN NATIONAL CANCER INSTITUTE   (India)

^b UNIVERSITY OF CINCINNATI   (United States)

^c MEDICAL COLLEGE AND HOSPITAL   (India)

^d INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

Author keywords

Amplification; bcl 1; CCND1; CCND2; CCND3; Head and neck squamous cell carcinoma; Rearrangement

Indexed keywords

CYCLIN D;

ADULT; AGED; ARTICLE; AUTORADIOGRAPHY; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DEMOGRAPHY; DISEASE COURSE; DYSPLASIA; FEMALE; GENE AMPLIFICATION; GENE CLUSTER; GENE LOCUS; GENE MUTATION; GENE REARRANGEMENT; HEAD AND NECK CARCINOMA; HUMAN; HUMAN TISSUE; INDIAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MOLECULAR CLONING; OUTCOME ASSESSMENT; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PROTO ONCOGENE; SOUTHERN BLOTTING; WART VIRUS;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CYCLINS; FEMALE; GENE AMPLIFICATION; GENES, BCL-1; HEAD AND NECK NEOPLASMS; HUMANS; INDIA; MALE; MIDDLE AGED; PROGNOSIS; TRANSLOCATION, GENETIC;

EID: 33645699472     PISSN: 10529551     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019606-200603000-00002     Document Type: Article

References (72)

1. Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer. 1999;80:827-841.
2. Parkin DM, Bray F, Ferlay J, et al. Estimating the world cancer burden: Globocan 2000. Int J Cancer. 2001;94:153-156.
3. Sankaranarayanan R, Masuyer E, Swaminathan R, et al. Head and neck cancer: a global perspective on epidemiology and prognosis. Anticancer Res. 1998;18:4779-4786.
4. Sen U, Sankaranarayanan R, Mandal S, et al. Cancer patterns in eastern India: The first report of the Kolkata Cancer Registry. Int J Cancer. 2002;100:86-91.
5. D'Costa J, Saranath D, Dedhia P, et al. Detection of HPV-16 gnome in human oral cancers and potentially malignant lesions from India. Oral Oncol. 1998;34:413-420.
6. Dahlgren L, Dahlstrand H, Lindquist D, et al. Human papilloma virus is more common in base of tongue than in mobile tongue cancer and is a favorable prognostic factor in base of tongue patients. Int J Cancer. 2004;112:1015-1019.
7. Jin Y, Mertens F, Jin C, et al. Nonrandom chromosome abnormalities in short term cultured primary squamous cell carcinomas of the head and neck. Cancer Res. 1995;55:3204-3210.
8. Van Dyke DL, Worsham MJ, Benninger MS, et al. Recurrent Cytogenetic abnormalities in squamous cell carcinomas of the head and neck region. Genes Chromosomes Cancer. 1994;9:192-206.
9. Speicher RM, Howe C, Crotty P, et al. Comparative genomic hybridization detects novel deletions and amplifications in head and neck squamous cell carcinomas. Cancer Res. 1995;55:1010-1013.
10. Rodriguez S, Khabir A, Keryer C, et al. conventional and array based comparative genomic hybridization analysis of nasopharyngeal carcinomas from the Mediterranean area. Cancer Genet Cytogenet. 2005;157:140-147.
11. Jiang RD, Hu L, Guan XY, et al. Comparative genomic hybridization analysis of nasopharyngeal carcinoma drug resistant cell CNE2/ DDP and its parent cell CNE2. Ai Zheng. 2004;23:386-390.
12. Gollin SM. Chromosomal alterations in squamous cell carcinomas of the head and neck: window to the biology of disease. Head Neck. 2001;23:238-253.
13. Motokura T, Arnold A. Cyclin D and oncogenesis. Curr Opin Genet Dev. 1993;3:5-10.
14. Jin Y, Hoglund M, Jin C, et al. FISH characterization of head and neck carcinomas reveals that amplification of band 11q13 is associated with deletion of distal 11q. Genes Chromosomes Cancer. 1998;22:312-320.
15. Jares P, Fernandez PL, Campo E, et al. PRAD1/cyclin D1 gene amplification correlates with messenger RNA over expression and tumor progression in human laryngeal carcinomas. Cancer Res. 1994;54:4813-4817.
16. Kyomoto R, Kumazawa H, Toda Y, et al. CYCLIN-D1 gene amplification is a more potent prognostic factor than its protein over-expression in human head and neck squamous cell carcinoma. Int J Cancer. 1997;74:576-581.
17. Miyamoto R, Uzawa N, Nagaoka S, et al. Prognostic significance of cyclin D1 amplification and over-expression in oral squamous cell carcinomas. Oral Oncol. 2003;39:610-618.
18. Akervall J, Borg A, Dictor M, et al. Chromosomal translocations involving 11q13 contributes to cyclin D1 over-expression in squamous cell carcinoma of the head and neck. Int J Oncol. 2002;20:45-52.
19. Schuuring E, Verhoeven E, Mooi J, et al. Identification of and cloning of two over expressed genes U21B31/PRAD1 and EMS1, within the amplified chromosome 11q13 region in human carcinomas. Oncogene. 1992;7:355-361.
20. Van Dyke D, Worsham MJ, Benninger MS, et al. Recurrent cytogenetic abnormalities in squamous cell carcinomas of head and neck region. Genes Chromosomes Cancer. 1994;9:192-206.
21. Sreekantaiah C, Rao PH, Xu L, et al. Consistent chromosomal losses in head and neck squamous cell carcinoma cell line. Genes Chromosomes Cancer. 1994;11:29-39.
22. Xu L, Davidson BJ, Murty VVVS, et al. TP53 mutation and CCND1 gene amplification in head and neck squamous cell carcinoma cell lines. Int J Cancer. 1994;59:383-387.
23. Callender T, El-Naggar AK, Lee MS, et al. PRAD1 (CCND1)/ cyclin D1 Oncogene amplification in primary head and neck squamous cell carcinoma. Cancer. 1994;74:152-158.
24. El-Naggar AK, Steck K, Batsakis JG. Heterogeneity of the proliferative fraction and cyclin D1/CCND1 gene amplification in head and neck squamous cell carcinoma. Cytometry. 1995;21:47-51.
25. Gaffey MJ, Iezzoni JC, Meredith SD, et al. Cyclin D1 (PRAD1, CCND1) and glutathione-S-transferase pi gene expression in head and neck squamous cell carcinoma. Hum Pathol. 1995;26:1221-1226.
26. Bartkova J, Lucas J, Muller H, et al. Abnormal pattern of D type cyclins expression and G1 regulation in human head and neck cancer. Cancer Res. 1995;55:949-956.
27. Bellacosa A, Almadori G, Cavallo S, et al. Cyclion D1 gene amplification in human Laryngeal squamous cell carcinomas: prognostic significance and clinical implications. Clin Cancer Res. 1996;2:175-180.
28. Mineta H, Borg A, Dictor M, et al. Correlation between p53 mutation and cyclin D1 amplification in head and neck squamous cell carcinoma. Oral Oncol. 1997;33:42-46.
29. Cattani P, Hohaus S, Bellacosa A, et al. Association between cyclin D1 (CCND1) gene amplification and human papillomavirus infection in human laryngeal squamous cell carcinoma. Clin Cancer Res. 1998;4:2585-2589.
30. Okami K, Red AL, Cairns P, et al. Cyclin D1 amplification is independent of p16 inactivation in head and neck squamous cell carcinoma. Oncogene. 1999;18:3541-3545.
31. Rodrigo JP, Garcia LA, Ramos S, et al. EMS1 gene amplification correlates with poor prognosis in squamous cell carcinoma of the head and neck. Clin Cancer Res. 2000;6:3177-3182.
32. Berenson JR, Yang J, Mickel RA. Frequent amplification of the bcl-1 locus in head and neck squamous cell carcinomas. Oncogene. 1989;4:1111-1116.
33. Lammie GA, Fantl V, Smith R, et al. D11S287, a putative oncogene on chromosome 11q13, is amplified and expressed in squamous cell and mammary carcinomas and linked to BCL-1. Oncogene. 1991;6:439-444.
34. Leonard JH, Kearsley JH, Chenevix-Trench G, et al. Analysis of gene amplification in head and neck squamous cell carcinomas. Int J Cancer. 1991;48:511-515.
35. Hall M, Peters G. Genetic alterations of cyclins, cyclin dependent Kinases and Cdk inhibitors in human cancer 1996. In: VandeWoude V, Klein G, eds. Advances in Cancer Research. California, USA: Academic Press, Inc.; 1996;68:67-108.
36. Donnellan R, Chetty R. Cyclin D1 and human neoplasia. Mol Pathol. 1998;51:1-7.
37. Schwab M. Amplification of oncogenes in human cancer cells. Bioessays. 1998;20:473-479.
38. Faust JB, Meeker TC. Amplification and expression of the bcl-1 gene in human solid tumor cell lines. Cancer Res. 1992;52:2460-2463.
39. Schuuring E. The involvement of the chromosome 11q13 region in human malignancies: Cyclin D1 and EMS1 are two new candidate oncogenes - A review. Gene. 1995;159:83-96.
40. Xiong Y, Menninger J, Beach D, et al. Molecular cloning and chromosomal mapping of CCND genes encoding human D-type cyclins. Genomics. 1992;13:575-584.
41. Diehl AJ. The cyclin D3 knockout: A pound of redundancy with a dash of tissue specificity. Cancer Biol Ther. 2004;3:162-164.
42. Bartkova J, Rajpert-de ME, Shakkebaek NE, et al. D-type cyclins in adult human testis and testicular cancer: Relation to cell type, proliferation, differentiation and malignancy. J Pathol. 1999;187:573-581.
43. Tamaru T, Okada M, Nakagawa H. Differential expression of D type cyclins during neuronal maturation. Neurosci Lett. 1994;168:229-232.
44. Kuchiki H, Saino M, Nobukuni T, et al. Detection of amplification of a chromosomal fragment at 6p21 including the cyclin D3 gene in a glioblastoma cell line by arbitrarily primed polymerase chain reaction. Int J Cancer. 2000;85:113-116.
45. Harmer MH (ed). UICC TNM Classification of Malignant Tumors, 3rd ed. Geneva: Union Internationale Contre le cancer (UICC); 1978.
46. Dasgupta S, Mukherjee N, Roy S, et al. Mapping of the candidate tumor suppressor genes' loci on human chromosome 3 in head and neck squamous cell carcinoma of Indian Patient Population. Oral Oncol. 2002;38:6-15.
47. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual, 2nd ed. New York: Cold Spring Harbor Laboratory; 1989.
48. Balaram P, Nalina Kumari KR, Abraham E, et al. Human Papillomaviruses in 91 oral cancers from Indian betel quid chewers-High prevalence and multiplicity of infections. Int J Cancer. 1995;61:450-454.
49. Gillison ML, Koch WM, Copone RB, et al. Evidence for a causal association between human papilloma virus and a subset of head and neck cancers. J Natl Cancer Inst. 2000;92:709-720.
50. Pokrovskaja K, Ehlin-Henriksson B, Bartkova J, et al. Phenotype-related differences in the expression of D-type cyclins in human B cell-derived lines. Cell Growth Differ. 1996;7:1723-1732.
51. Mondal G, Tripathi A, Bhattacharya N, et al. Allelic imbalance at chromosome 11 in head and neck squamous cell carcinoma in an Indian Patient Population. J Clin Pathol. 2003;56:512-518.
52. Krissansen GW, Owen MJ, Verbi M, et al. Primary structure of the T3 γ subunit of the T3/T cell antigen receptor complex deduced from cDNA sequences: evolution of the T3 γ and δ subunits. EMBO J. 1986;8:1799-1808.
53. Singh RK, Dasgupta S, Bhattacharya N, et al. Deletion in chromosome 11 and bcl-1/cyclin D1 alterations are independently associated with the development of uterine cervical carcinoma. J Cancer Res Clin Oncol. 2005;131:395-406.
54. Motokura T, Arnold A. Cyclins and oncogenesis. Biochim Biophys Acta. 1993;1155:63-78.
55. Shinozaki H, Ozawa S, Ando N, et al. Cyclin D1 amplification as a new predictive classification for squamous cell carcinoma of the esophagus, adding gene information. Clin Cancer Res. 1996;2:1155-1161.
56. Nakagawa H, Zukerberg L, Togawa K, et al. Human cyclin D1 oncogene and esophageal squamous cell carcinoma. Cancer. 1995;76:541-549.
57. Courjal F, Louason G, Speiser P, et al. Cyclin gene amplification and overexpression in breast and ovarian cancers: for the selection of cyclin D1 in breast and cyclin E in ovarian tumors. Int J Cancer. 1996;69:247-253.
58. Vos CBJ, Haar NTT, Peterse JL, et al. Cyclin D1 gene amplification and overexpression are present in ductal carcinoma in situ of the breast. J Pathol. 1999;187:279-284.
59. Nimeus N, Baldetorp B, Bendahl P, et al. Amplification of the cyclin D1 gene is associated with tumor subsite, DNA non-diploidy and high S-phase fraction in squamous cell carcinoma of the head and neck. Oral Oncol. 2004;40:624-629.
60. Schneeberger C, Eder S, Swoboda H, et al. A differential PCR system for the detarmination of CCND1 gene amplification in head and neck squamous cell carcinomas. Oral Oncol. 1998;34:257-260.
61. Almadori G, Galll J, Cadoni G, et al. Human papillomavirus infection and cyclin D1 gene amplification in laryngeal squamous cell carcinoma: Biologic function and clinical significance. Head Neck. 2002;24:597-604.
62. Sauders WS, Shuster S, Huang X, et al. Chromosomal instability and cytoskeletal defects in oral cancer cells. Proc Natl Acad Sci USA. 2000;97:303-308.
63. Hoglund M, Johansson B, Pedersen-Bjergaard J, et al. Molecular characterization of 12p abnormalities in hematologic malignancies: Deletions of KIP1, rearrangement of TEL and amplification of CCND2. Blood. 1996;87:324-330.
64. Leach FS, Elledge SJ, Sherr CJ, et al. Amplification of cyclin genes in colorectal carcinomas. Cancer Res. 1993;53:1986-1989.
65. Kuchiki H, Saino M, Nobukuni T, et al. Detection of amplification of a chromosomal fragment at 6p21 including the cyclin D3 gene in a glioblastoma cell line by arbitrarily primed polymerase chain reaction. Int J Cancer. 2000;85:113-116.
66. Schmidt BA, Rose A, Steinhoff C, et al. Up-regulation of cyclin-dependent kinase 4/cyclin D2 expression but down-regulation of cyclin-dependent kinase 2/cyclin E in testicular germ cell tumors. Cancer Res. 2001;61:4214-4221.
67. Delmer A, Ajchenbaum-Cymbalista F, Tang R, et al. Overexpression of cyclin D2 in chronic B-cell malignancies. Blood. 1995;85:2870-2876.
68. Takano Y, Kato Y, van Diest PJ, et al. Cyclin D2 over-expression and lack of p27 correlate positively and cyclin E inversely with poor prognosis in gastric cancer cases. Am J Pathol. 2000;156:585-594.
69. Bartkova J, Zemanova M, Bartek J. Abundance and subcellular localization of cyclin D3 in human tumors. Int J Cancer. 1996;65:323-327.
70. Chakraborty SB, Dasgupta S, Roy A, et al. Differential deletions in chromosome 3p are associated with development of head and neck squamous cell carcinoma from Indian patients. Cancer Genet Cytogenet 2003;145:1-9.
71. Vernon SD, Unger ER, Miller DL, et al. Association of human papillomavirus type 16 interaction in the E2 gene with poor disease-free survival from cervical cancer. Int J Cancer. 1997;74:50-56.
72. INK4A expression predict reduced survival in carcinoma of the anterior tongue. Clin Cancer Res. 1999;5:2810-2819.